House Staffer: Lawmakers Focused More On HRSA's Authority Over 340B Than CMS' Proposal

A senior House Republican staffer said congressional discussions continue on whether the Health Resources and Services Administration has adequate authority and resources to run the 340B drug discount program, and added it is unclear how CMS' recent proposal to cut Medicare pay for hospitals might affect lawmakers’ oversight. One lobbyist suggested the most likely path for bipartisan 340B legislation could be to nullify CMS' proposal while also giving HRSA more authority to run the program. Just prior to the House...